Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
12-14 August, 2025
Not Confirmed
Not Confirmed
17-21 August, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
12-14 August, 2025
Industry Trade Show
Not Confirmed
17-21 August, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
25 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/lts-and-nualtis-announce-strategic-cooperation-to-expand-global-manufacturing-capabilities-accelerate-market-expansion-and-ensure-customer-success-302490826.html
11 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/11/3097527/0/en/IntelGenx-Announces-Rebranding-to-Nualtis-Signaling-Strategic-Evolution-and-Renewed-Vision.html
02 Oct 2024
// PRESS RELEASE
https://www.intelgenx.com/newsrooms/newsrooms1/134-2024-news/1020-ntelenxisrantedourtpprovalofthealeroposalfr20241002
19 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/19/2916059/0/en/IntelGenx-Provides-Update-on-Previously-Announced-Sale-and-Investment-Solicitation-Process.html
03 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/03/2908117/0/en/IntelGenx-Obtains-Preliminary-Efficacy-Results-for-the-BUENA-Montelukast-VersaFilm-Phase-2a-Clinical-Trial-in-Patients-with-Mild-to-Moderate-Alzheimer-s-Disease.html
11 Jun 2024
// PRESS RELEASE
https://www.intelgenx.com/newsrooms/newsrooms1/134-2024-news/1017-ntelenxnnouncesnitiationofthealeandnvestment20240611
ABOUT THIS PAGE